Identification of a Novel FGFR2 Gene Mutation (c.514_515delinsCT, p.Ala172Leu) in a Chinese Neonate With Apert Syndrome: A Case Report.

IF 1.7 4区 生物学 Q3 GENETICS & HEREDITY
Dongxue Pan, Xiufang Yang
{"title":"Identification of a Novel FGFR2 Gene Mutation (c.514_515delinsCT, p.Ala172Leu) in a Chinese Neonate With Apert Syndrome: A Case Report.","authors":"Dongxue Pan, Xiufang Yang","doi":"10.1002/ajmg.a.64158","DOIUrl":null,"url":null,"abstract":"<p><p>Apert syndrome (AS) is a rare autosomal dominant congenital disorder characterized by craniosynostosis, midfacial hypoplasia, and syndactyly. Most cases are caused by mutations in the fibroblast growth factor receptor 2 (FGFR2) gene, primarily S252W and P253R mutations, more than 98% resulting from de novo mutations. The FGFR2 gene encodes a receptor tyrosine kinase protein, which is essential for embryonic development and skeletal formation. The study reported a Chinese newborn diagnosed with AS, attributed to a novel FGFR2 gene mutation, c.514_515delinsCT (p. Ala172Leu), identified through whole exome sequencing (WES). The proband was a male infant born at 38<sup>+5</sup> weeks of gestation to non-consanguineous parents. At birth, he exhibited craniofacial abnormalities, including frontal bossing, proptosis, hypertelorism, and a hooked nose, along with syndactyly of the hands and feet. Additional findings included congenital heart defects, bronchial stenosis, and hyperhidrosis. Genetic testing revealed a novel FGFR2 mutation, c.514_515delinsCT (p. Ala172Leu), which was absent in his parents, confirming a de novo mutation. Protein structure prediction using AlphaFold and PyMOL demonstrated significant structural differences between the wild-type and mutant proteins, with an RMSD value of 11.147 Å. This mutation likely disrupts FGFR2's ligand-binding ability, leading to aberrant activation and contributing to the clinical features observed. This case presents a novel FGFR2 mutation, expanding the spectrum of genetic variants associated with AS. The findings underscore the importance of genetic testing and protein structure analysis in diagnosing atypical cases and understanding genotype-phenotype correlations. Further studies with larger cohorts are needed to elucidate the molecular mechanisms underlying AS and develop personalized diagnostic and therapeutic approaches for this complex disorder.</p>","PeriodicalId":7507,"journal":{"name":"American Journal of Medical Genetics Part A","volume":" ","pages":"e64158"},"PeriodicalIF":1.7000,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Medical Genetics Part A","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1002/ajmg.a.64158","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0

Abstract

Apert syndrome (AS) is a rare autosomal dominant congenital disorder characterized by craniosynostosis, midfacial hypoplasia, and syndactyly. Most cases are caused by mutations in the fibroblast growth factor receptor 2 (FGFR2) gene, primarily S252W and P253R mutations, more than 98% resulting from de novo mutations. The FGFR2 gene encodes a receptor tyrosine kinase protein, which is essential for embryonic development and skeletal formation. The study reported a Chinese newborn diagnosed with AS, attributed to a novel FGFR2 gene mutation, c.514_515delinsCT (p. Ala172Leu), identified through whole exome sequencing (WES). The proband was a male infant born at 38+5 weeks of gestation to non-consanguineous parents. At birth, he exhibited craniofacial abnormalities, including frontal bossing, proptosis, hypertelorism, and a hooked nose, along with syndactyly of the hands and feet. Additional findings included congenital heart defects, bronchial stenosis, and hyperhidrosis. Genetic testing revealed a novel FGFR2 mutation, c.514_515delinsCT (p. Ala172Leu), which was absent in his parents, confirming a de novo mutation. Protein structure prediction using AlphaFold and PyMOL demonstrated significant structural differences between the wild-type and mutant proteins, with an RMSD value of 11.147 Å. This mutation likely disrupts FGFR2's ligand-binding ability, leading to aberrant activation and contributing to the clinical features observed. This case presents a novel FGFR2 mutation, expanding the spectrum of genetic variants associated with AS. The findings underscore the importance of genetic testing and protein structure analysis in diagnosing atypical cases and understanding genotype-phenotype correlations. Further studies with larger cohorts are needed to elucidate the molecular mechanisms underlying AS and develop personalized diagnostic and therapeutic approaches for this complex disorder.

中国新生儿Apert综合征中FGFR2基因突变(c.514_515delinsCT, p.Ala172Leu)的鉴定:1例报告
Apert综合征(AS)是一种罕见的常染色体显性先天性疾病,以颅缝闭合、面中部发育不全和并指畸形为特征。大多数病例是由成纤维细胞生长因子受体2 (FGFR2)基因突变引起的,主要是S252W和P253R突变,超过98%是由新生突变引起的。FGFR2基因编码一种受体酪氨酸激酶蛋白,该蛋白对胚胎发育和骨骼形成至关重要。该研究报告了一名中国新生儿被诊断为AS,归因于一种新的FGFR2基因突变,c.514_515delinsCT (p. Ala172Leu),通过全外显子组测序(WES)鉴定。先证者为一名非近亲父母在妊娠38+5周时出生的男婴。出生时,他表现出颅面畸形,包括额部隆起、突出、远距、钩鼻,以及手和脚并指。其他发现包括先天性心脏缺陷、支气管狭窄和多汗症。基因检测显示了一种新的FGFR2突变,c.514_515delinsCT (p. Ala172Leu),这在他的父母中是不存在的,证实了一种新生突变。利用AlphaFold和PyMOL进行蛋白结构预测,野生型和突变型蛋白的结构差异显著,RMSD值为11.147 Å。这种突变可能会破坏FGFR2的配体结合能力,导致异常激活并导致观察到的临床特征。该病例呈现出一种新的FGFR2突变,扩大了与AS相关的遗传变异谱。这些发现强调了基因检测和蛋白质结构分析在诊断非典型病例和理解基因型-表型相关性方面的重要性。进一步的研究需要更大的队列来阐明AS的分子机制,并为这种复杂疾病开发个性化的诊断和治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.50
自引率
5.00%
发文量
432
审稿时长
2-4 weeks
期刊介绍: The American Journal of Medical Genetics - Part A (AJMG) gives you continuous coverage of all biological and medical aspects of genetic disorders and birth defects, as well as in-depth documentation of phenotype analysis within the current context of genotype/phenotype correlations. In addition to Part A , AJMG also publishes two other parts: Part B: Neuropsychiatric Genetics , covering experimental and clinical investigations of the genetic mechanisms underlying neurologic and psychiatric disorders. Part C: Seminars in Medical Genetics , guest-edited collections of thematic reviews of topical interest to the readership of AJMG .
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信